{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:04:37Z","timestamp":1789758277870,"version":"4.0.1"},"reference-count":195,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP3DK108209"],"award-info":[{"award-number":["DP3DK108209"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL092969"],"award-info":[{"award-number":["P01HL092969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK017047"],"award-info":[{"award-number":["P30DK017047"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL126028"],"award-info":[{"award-number":["R01HL126028"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL127694"],"award-info":[{"award-number":["R01HL127694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00504","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T14:44:16Z","timestamp":1597329856000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models"],"prefix":"10.3389","volume":"11","author":[{"given":"Debapriya","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin E.","family":"Bornfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJM198006193022503","article-title":"Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease","volume":"302","author":"Hulley","year":"1980","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/nu5030981","article-title":"Hypertriglyceridemia","volume":"5","author":"Brahm","year":"2013","journal-title":"Nutrients."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S0140-6736(77)92717-9","article-title":"Type-III Hyperlipoproteinaemia (\u201cremnant removal disease\u201d). Insight into the pathogenetic mechanism","volume":"1","author":"Chait","year":"1977","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/13543784.2019.1696772","article-title":"Investigational drugs in development for hypertriglyceridemia: a coming-of-age story","volume":"28","author":"Rhainds","year":"2019","journal-title":"Expert Opin Investig Drugs."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1073\/pnas.86.15.5810","article-title":"Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins","volume":"86","author":"Kowal","year":"1989","journal-title":"Proc Natl Acad Sci USA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1172\/JCI1240","article-title":"Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants","volume":"101","author":"Rohlmann","year":"1998","journal-title":"J Clin Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1172\/JCI11750","article-title":"LDL receptor-related protein mediates cell-surface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice","volume":"107","author":"Yu","year":"2001","journal-title":"J Clin Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1172\/JCI111044","article-title":"Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic","volume":"72","author":"Brown","year":"1983","journal-title":"J Clin Invest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11883-017-0667-9","article-title":"Genetics of triglycerides and the risk of atherosclerosis","volume":"19","author":"Dron","year":"2017","journal-title":"Curr Atheroscler Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jacl.2020.01.003","article-title":"The polygenic nature of mild-to-moderate hypertriglyceridemia","volume":"14","author":"Dron","year":"2020","journal-title":"J Clin Lipidol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/joim.13016","article-title":"Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia","volume":"287","author":"Baass","year":"2019","journal-title":"J Intern Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMoa1611930","article-title":"Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia","volume":"376","author":"Beigneux","year":"2017","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1073\/pnas.1920202117","article-title":"Unfolding of monomeric lipoprotein lipase by ANGPTL4: insight into the regulation of plasma triglyceride metabolism","volume":"117","author":"Kristensen","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1172\/JCI107331","article-title":"Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction","volume":"52","author":"Goldstein","year":"1973","journal-title":"J Clin Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American heart association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation."},{"key":"B17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/er.2018-00184","article-title":"The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk","volume":"40","author":"Sandesara","year":"2019","journal-title":"Endocr Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/ATVBAHA.119.312336","article-title":"Elevated serum non-hdl (high-density lipoprotein) cholesterol and triglyceride levels as residual risks for myocardial infarction recurrence under statin treatment","volume":"39","author":"Suzuki","year":"2019","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jacc.2019.06.043","article-title":"Reduction in first and total ischemic events with icosapent ethyl across baseline triglyceride tertiles","volume":"74","author":"Bhatt","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2337\/dbi19-0007","article-title":"Remnants of the triglyceride-rich lipoproteins, diabetes and cardiovascular disease","volume":"69","author":"Chait","year":"2020","journal-title":"Diabetes."},{"key":"B24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.7326\/0003-4819-82-2-158","article-title":"The biochemical, clinical, and genetic features of type III hyperlipoproteinemia","volume":"82","author":"Morganroth","year":"1975","journal-title":"Ann Intern Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2015.02.046","article-title":"Vascular risk factors, vascular disease, lipids and lipid targets in patients with familial dysbetalipoproteinemia: a European cross-sectional study","volume":"240","author":"Koopal","year":"2015","journal-title":"Atherosclerosis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.jacc.2014.09.042","article-title":"Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease","volume":"64","author":"Rosenson","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1161\/01.RES.33.6.633","article-title":"A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins","volume":"33","author":"Zilversmit","year":"1973","journal-title":"Circ Res."},{"key":"B30","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1016\/S0021-9258(17)39420-6","article-title":"Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages","volume":"260","author":"Van Lenten","year":"1985","journal-title":"J Biol Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1161\/01.ATV.17.9.1707","article-title":"Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation","volume":"17","author":"Whitman","year":"1997","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/cts.12538","article-title":"It's time to reverse our thinking: the reverse translation research paradigm","volume":"11","author":"Shakhnovich","year":"2018","journal-title":"Clin Transl Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell."},{"key":"B34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science."},{"key":"B35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/CIRCRESAHA.107.156554","article-title":"Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet","volume":"102","author":"Zhang","year":"2008","journal-title":"Circul Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/ATVBAHA.109.196329","article-title":"Chylomicronemia elicits atherosclerosis in mice\u2013brief report","volume":"30","author":"Weinstein","year":"2010","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0005-2760(89)90346-9","article-title":"Impaired triacylglycerol catabolism in hypertriglyceridemia of the diabetic, cholesterol-fed rabbit: a possible mechanism for protection from atherosclerosis","volume":"1002","author":"Minnich","year":"1989","journal-title":"Biochim Biophys Acta."},{"key":"B38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1084\/jem.89.6.611","article-title":"The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit","volume":"89","author":"Duff","year":"1949","journal-title":"J Exp Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0021-9150(97)00051-8","article-title":"Intermediate density lipoprotein cholesterol as the best lipoprotein predictor of atherosclerosis severity in the watanabe heritable hyperlipidemic rabbit","volume":"132","author":"Nordestgaard","year":"1997","journal-title":"Atherosclerosis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1172\/JCI117117","article-title":"Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice","volume":"93","author":"van Vlijmen","year":"1994","journal-title":"J Clin Invest."},{"key":"B41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/01.ATV.20.1.119","article-title":"Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158\u2013>Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice","volume":"20","author":"Van Eck","year":"2000","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.atherosclerosis.2019.06.174","article-title":"Effect Of Lipoprotein Lipase (Lpl) deletion on atherosclerosis regression","volume":"287","author":"Basu","year":"2019","journal-title":"Atherosclerosis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1073\/pnas.93.14.7242","article-title":"Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase","volume":"93","author":"Shimada","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"B44","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0022-2275(20)33414-3","article-title":"Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice","volume":"40","author":"Yagyu","year":"1999","journal-title":"J Lipid Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1172\/JCI127308","article-title":"Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes","volume":"130","author":"Kanter","year":"2019","journal-title":"J Clin Invest."},{"key":"B46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1126\/science.275.5298.391","article-title":"A mouse model with features of familial combined hyperlipidemia","volume":"275","author":"Masucci-Magoulas","year":"1997","journal-title":"Science."},{"key":"B47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/cvr\/cvv192","article-title":"Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII","volume":"107","author":"Li","year":"2015","journal-title":"Cardiovasc Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCRESAHA.108.179861","article-title":"Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia","volume":"103","author":"Mansouri","year":"2008","journal-title":"Circ Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1161\/ATVBAHA.116.307790","article-title":"Loss of transcription factor CREBH accelerates diet-induced atherosclerosis in Ldlr-\/- Mice","volume":"36","author":"Park","year":"2016","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1701329","article-title":"Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides","volume":"377","author":"Graham","year":"2017","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.bbrc.2008.12.018","article-title":"Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis","volume":"379","author":"Adachi","year":"2009","journal-title":"Biochem Biophys Res Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1073\/pnas.0709958105","article-title":"Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice","volume":"105","author":"Johansson","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B53","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1172\/JCI200417867","article-title":"Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions","volume":"114","author":"Renard","year":"2004","journal-title":"J Clin Invest."},{"key":"B54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4615-5763-0_13","article-title":"Cardiovascular disease in the JCR:LA-cp rat","volume":"188","author":"Russell","year":"1998","journal-title":"Mol Cell Biochem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1476-511X-13-144","article-title":"Occlusal disharmony accelerates the initiation of atherosclerosis in apoE knockout rats","volume":"13","author":"Ekuni","year":"2014","journal-title":"Lipids Health Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1038\/s41598-018-23835-z","article-title":"Long-term Western diet fed apolipoprotein E-deficient rats exhibit only modest early atherosclerotic characteristics","volume":"8","author":"Rune","year":"2018","journal-title":"Sci Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.atherosclerosis.2018.02.015","article-title":"Hyperlipidemia induces typical atherosclerosis development in Ldlr and Apoe deficient rats","volume":"271","author":"Zhao","year":"2018","journal-title":"Atherosclerosis."},{"key":"B58","first-page":"I33","article-title":"Watanabe heritable hyperlipidemic rabbit. Animal model for familial hypercholesterolemia","volume":"9","author":"Havel","year":"1989","journal-title":"Arteriosclerosis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12986-015-0024-3","article-title":"High-fructose and high-fat diet-induced insulin resistance enhances atherosclerosis in Watanabe heritable hyperlipidemic rabbits","volume":"12","author":"Ning","year":"2015","journal-title":"Nutr Metab."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/nu6031236","article-title":"The role of hypertriglyceridemia in the development of atherosclerosis and endothelial dysfunction","volume":"6","author":"Matsumoto","year":"2014","journal-title":"Nutrients."},{"key":"B61","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/genetics\/132.4.1095","article-title":"A genetic model for control of hypertriglyceridemia and apolipoprotein B levels in the Johns Hopkins colony of St. Thomas Hospital rabbits","volume":"132","author":"Beaty","year":"1992","journal-title":"Genetics."},{"key":"B62","unstructured":"The obese gottingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile1505 JohansenT HansenHS RichelsenB MalmlofR 11922179Comp Med.512001"},{"key":"B63","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1242\/dmm.019836","article-title":"Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia","volume":"8","author":"Liu","year":"2015","journal-title":"Dis Model Mech."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1172\/JCI117179","article-title":"Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice","volume":"93","author":"Ishibashi","year":"1994","journal-title":"J Clin Invest."},{"key":"B65","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1194\/jlr.R800058-JLR200","article-title":"Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall","volume":"50","author":"Getz","year":"2009","journal-title":"J Lipid Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"13079","DOI":"10.1074\/jbc.M111.229369","article-title":"Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice","volume":"286","author":"Basford","year":"2011","journal-title":"J Biol Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1172\/JCI86610","article-title":"ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors","volume":"126","author":"Gordts","year":"2016","journal-title":"J Clin Invest."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1182\/blood-2003-11-4051","article-title":"Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol","volume":"103","author":"Espirito Santo","year":"2004","journal-title":"Blood."},{"key":"B69","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00291607","article-title":"Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia","volume":"73","author":"Havekes","year":"1986","journal-title":"Hum Genet."},{"key":"B70","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1016\/S0021-9258(18)82232-3","article-title":"Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia","volume":"268","author":"van den Maagdenberg","year":"1993","journal-title":"J Biol Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.atherosclerosis.2007.01.015","article-title":"Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages","volume":"195","author":"Westerterp","year":"2007","journal-title":"Atherosclerosis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1194\/jlr.M400301-JLR200","article-title":"Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL","volume":"46","author":"Berbee","year":"2005","journal-title":"J Lipid Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/01.ATV.16.8.934","article-title":"Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1","volume":"16","author":"Jong","year":"1996","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.bbalip.2012.02.005","article-title":"Triglyceride: one molecule at the center of health and disease","volume":"1821","author":"Goldberg","year":"2012","journal-title":"Biochim Biophys Acta."},{"key":"B75","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-2275(20)37569-6","article-title":"Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis","volume":"37","author":"Goldberg","year":"1996","journal-title":"J Lipid Res."},{"key":"B76","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-2275(20)37713-0","article-title":"High density lipoprotein metabolism","volume":"25","author":"Eisenberg","year":"1984","journal-title":"J Lipid Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI113354","article-title":"Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey","volume":"81","author":"Goldberg","year":"1988","journal-title":"J Clin Invest."},{"key":"B78","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1172\/JCI114732","article-title":"Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys","volume":"86","author":"Goldberg","year":"1990","journal-title":"J Clin Invest."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1172\/JCI115747","article-title":"Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques","volume":"89","author":"O'Brien","year":"1992","journal-title":"J Clin Invest."},{"key":"B80","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1073\/pnas.1900983116","article-title":"Lipoprotein lipase is active as a monomer","volume":"116","author":"Beigneux","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B81","unstructured":"Familial lipoprotein lipase deficiency BurnettJR HooperAJ HegeleRA AdamMP ArdingerHH PagonRA WallaceSE BeanLJH StephensK AmemiyaA Seattle, WAUniversity of WashingtonGeneReviews\u00ae [Internet]1993"},{"key":"B82","doi-asserted-by":"publisher","first-page":"36083","DOI":"10.1074\/jbc.M104430200","article-title":"Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice","volume":"276","author":"Strauss","year":"2001","journal-title":"J Biol Chem."},{"key":"B83","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/ATVBAHA.107.153239","article-title":"In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation","volume":"28","author":"Takahashi","year":"2008","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"17182","DOI":"10.1074\/jbc.272.27.17182","article-title":"Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma","volume":"272","author":"Levak-Frank","year":"1997","journal-title":"J Biol Chem."},{"key":"B85","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1073\/pnas.96.6.3165","article-title":"Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels","volume":"96","author":"Levak-Frank","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B86","doi-asserted-by":"publisher","first-page":"25050","DOI":"10.1074\/jbc.M401028200","article-title":"Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression","volume":"279","author":"Augustus","year":"2004","journal-title":"J Biol Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"37976","DOI":"10.1074\/jbc.M110.174458","article-title":"Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake","volume":"285","author":"Bharadwaj","year":"2010","journal-title":"J Biol Chem."},{"key":"B88","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0022-2275(20)32538-4","article-title":"Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice","volume":"39","author":"Semenkovich","year":"1998","journal-title":"J Lipid Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1172\/JCI6117","article-title":"Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo","volume":"103","author":"Babaev","year":"1999","journal-title":"J Clin Invest."},{"key":"B90","doi-asserted-by":"publisher","first-page":"26293","DOI":"10.1074\/jbc.M002423200","article-title":"Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice","volume":"275","author":"Babaev","year":"2000","journal-title":"J Biol Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1194\/jlr.M035568","article-title":"Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity","volume":"54","author":"Takahashi","year":"2013","journal-title":"J Lipid Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0021-9150(01)00510-X","article-title":"No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61 -> Stop) in the lipoprotein lipase gene","volume":"159","author":"Ebara","year":"2001","journal-title":"Atherosclerosis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cca.2007.08.011","article-title":"A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis","volume":"386","author":"Ebara","year":"2007","journal-title":"Clin Chim Acta."},{"key":"B94","doi-asserted-by":"publisher","first-page":"6541","DOI":"10.1210\/jc.2005-1098","article-title":"Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPLArita in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis","volume":"90","author":"Kawashiri","year":"2005","journal-title":"J Clin Endocrinol Metabol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1161\/01.CIR.96.6.1737","article-title":"Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease","volume":"96","author":"Nordestgaard","year":"1997","journal-title":"Circulation."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1161\/01.CIR.94.8.1913","article-title":"The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS study group, interuniversity cardiology institute, utrecht, The Netherlands. Regression growth evaluation statin study","volume":"94","author":"Jukema","year":"1996","journal-title":"Circulation."},{"key":"B97","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cmet.2007.02.002","article-title":"Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons","volume":"5","author":"Beigneux","year":"2007","journal-title":"Cell Metab."},{"key":"B98","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cmet.2019.05.023","article-title":"GPIHBP1 and lipoprotein lipase, partners in plasma triglyceride metabolism","volume":"30","author":"Young","year":"2019","journal-title":"Cell Metab."},{"key":"B99","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1194\/jlr.ILR120000735","article-title":"GPIHBP1, a partner protein for lipoprotein lipase, is expressed only in capillary endothelial cells","volume":"61","author":"Meng","year":"2020","journal-title":"J Lipid Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cmet.2010.04.016","article-title":"GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries","volume":"12","author":"Davies","year":"2010","journal-title":"Cell Metab."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1194\/jlr.M031559","article-title":"Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells","volume":"53","author":"Davies","year":"2012","journal-title":"J Lipid Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cmet.2014.01.017","article-title":"The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries","volume":"19","author":"Goulbourne","year":"2014","journal-title":"Cell Metab."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e12095","DOI":"10.7554\/eLife.12095","article-title":"The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain","volume":"5","author":"Mysling","year":"2016","journal-title":"Elife."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e20958","DOI":"10.7554\/eLife.20958","article-title":"The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding","volume":"5","author":"Mysling","year":"2016","journal-title":"eLife."},{"key":"B105","doi-asserted-by":"publisher","first-page":"10360","DOI":"10.1073\/pnas.1820171116","article-title":"Structure of lipoprotein lipase in complex with GPIHBP1","volume":"116","author":"Arora","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1073\/pnas.1817984116","article-title":"Structure of the lipoprotein lipase-GPIHBP1 complex that mediates plasma triglyceride hydrolysis","volume":"116","author":"Birrane","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B107","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2019.01.025","article-title":"Gpihbp1 deficiency accelerates atherosclerosis and plaque instability in diabetic Ldlr(-\/-) mice","volume":"282","author":"Liu","year":"2019","journal-title":"Atherosclerosis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.6857276","article-title":"Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse","volume":"221","author":"Paterniti","year":"1983","journal-title":"Science."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/ng.2007.24","article-title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia","volume":"39","author":"Peterfy","year":"2007","journal-title":"Nat Genet."},{"key":"B110","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/S0022-2275(20)32428-7","article-title":"cld and lec23 are disparate mutations that affect maturation of lipoprotein lipase in the endoplasmic reticulum","volume":"40","author":"Briquet-Laugier","year":"1999","journal-title":"J Lipid Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/ATVBAHA.112.245696","article-title":"Transgenic expression and genetic variation of Lmf1 affect LPL activity in mice and humans","volume":"32","author":"Hosseini","year":"2012","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1194\/jlr.M900196-JLR200","article-title":"A quantitative assay measuring the function of lipase maturation factor 1","volume":"50","author":"Yin","year":"2009","journal-title":"J Lipid Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1210\/jc.2009-0594","article-title":"Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia","volume":"94","author":"Cefalu","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B114","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/CIRCGENETICS.111.960864","article-title":"Excess of rare variants in non-genome-wide association study candidate genes in patients with hypertriglyceridemia","volume":"5","author":"Johansen","year":"2012","journal-title":"Circ Cardiovasc Genet."},{"key":"B115","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2017.10.025","article-title":"Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism","volume":"267","author":"Wolska","year":"2017","journal-title":"Atherosclerosis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1021\/bi0267184","article-title":"Global structure and dynamics of human apolipoprotein CII in complex with micelles: evidence for increased mobility of the helix involved in the activation of lipoprotein lipase","volume":"42","author":"Zdunek","year":"2003","journal-title":"Biochemistry."},{"key":"B117","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/S0021-9258(18)62574-8","article-title":"Further characterization of apolipoproteins from the human plasma very low density lipoproteins","volume":"245","author":"Brown","year":"1970","journal-title":"J Biol Chem."},{"key":"B118","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0006-291X(70)90468-7","article-title":"A specific apoprotein activator for lipoprotein lipase","volume":"41","author":"LaRosa","year":"1970","journal-title":"Biochem Biophys Res Commun."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1210\/jc.2016-3903","article-title":"A novel APOC2 missense mutation causing apolipoprotein c-ii deficiency with severe triglyceridemia and pancreatitis","volume":"102","author":"Ueda","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B120","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1124\/jpet.115.229740","article-title":"Creation of Apolipoprotein C-II (ApoC-II) mutant mice and correction of their hypertriglyceridemia with an ApoC-II Mimetic Peptide","volume":"356","author":"Sakurai","year":"2016","journal-title":"J Pharmacol Exp Ther."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.4390","article-title":"A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels","volume":"23","author":"Khetarpal","year":"2017","journal-title":"Nat Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11883-019-0791-9","article-title":"Emerging evidence that apoc-iii inhibitors provide novel options to reduce the residual CVD","volume":"21","author":"Taskinen","year":"2019","journal-title":"Curr Atheroscler Rep."},{"key":"B124","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0022-2275(20)40584-X","article-title":"Very low density lipoprotein. Fate of phospholipids, cholesterol, and apolipoprotein C during lipolysis in vitro","volume":"20","author":"Eisenberg","year":"1979","journal-title":"J Lipid Res."},{"key":"B125","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/meta.2001.19452","article-title":"Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins","volume":"50","author":"Marcoux","year":"2001","journal-title":"Metabolism."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1194\/jlr.M078220","article-title":"Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL","volume":"58","author":"Larsson","year":"2017","journal-title":"J Lipid Res."},{"key":"B127","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0014-5793(76)80145-7","article-title":"Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase","volume":"65","author":"Kinnunen","year":"1976","journal-title":"FEBS Lett."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1194\/jlr.M093740","article-title":"ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance","volume":"60","author":"Ramms","year":"2019","journal-title":"J Lipid Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1042\/bj3210445","article-title":"Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice","volume":"321","author":"Jong","year":"1997","journal-title":"Biochem J."},{"key":"B130","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1126\/science.2167514","article-title":"Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice","volume":"249","author":"Ito","year":"1990","journal-title":"Science."},{"key":"B131","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12944-018-0867-5","article-title":"Increased inflammation, endoplasmic reticulum stress and oxidative stress in endothelial and macrophage cells exacerbate atherosclerosis in ApoCIII transgenic mice","volume":"17","author":"Yingchun","year":"2018","journal-title":"Lipids Health Dis."},{"key":"B132","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41590-019-0548-1","article-title":"Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation","volume":"21","author":"Zewinger","year":"2020","journal-title":"Nat Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1161\/CIRCULATIONAHA.105.591743","article-title":"Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells","volume":"113","author":"Kawakami","year":"2006","journal-title":"Circulation."},{"key":"B134","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.106.622514","article-title":"Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells","volume":"114","author":"Kawakami","year":"2006","journal-title":"Circulation."},{"key":"B135","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science."},{"key":"B136","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1194\/jlr.M700281-JLR200","article-title":"Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice","volume":"49","author":"Nelbach","year":"2008","journal-title":"J Lipid Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1194\/jlr.M054080","article-title":"ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content","volume":"56","author":"Camporez","year":"2015","journal-title":"J Lipid Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"21553","DOI":"10.1074\/jbc.M411412200","article-title":"Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase","volume":"280","author":"Merkel","year":"2005","journal-title":"J Biol Chem."},{"key":"B139","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10545-008-0863-4","article-title":"Apoprotein A-V: an important regulator of triglyceride metabolism","volume":"31","author":"Kluger","year":"2008","journal-title":"J Inherit Metab Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nm.2347","article-title":"The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism","volume":"17","author":"Lee","year":"2011","journal-title":"Nat Med."},{"key":"B141","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J Clin Lipidol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1101\/gr.099234.109","article-title":"A high-resolution association mapping panel for the dissection of complex traits in mice","volume":"20","author":"Bennett","year":"2010","journal-title":"Genome Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.cmet.2018.12.013","article-title":"Gene-by-sex interactions in mitochondrial functions and cardio-metabolic traits","volume":"29","author":"Norheim","year":"2019","journal-title":"Cell Metab."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e1005711","DOI":"10.1371\/journal.pgen.1005711","article-title":"Genetic architecture of atherosclerosis in mice: a systems genetics analysis of common inbred strains","volume":"11","author":"Bennett","year":"2015","journal-title":"PLoS Genet."},{"key":"B146","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1161\/ATVBAHA.114.304615","article-title":"Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice","volume":"35","author":"Willecke","year":"2015","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1161\/ATVBAHA.117.310358","article-title":"Suppression of hepatic FLOT1 (Flotillin-1) by type 2 diabetes mellitus impairs the disposal of remnant lipoproteins via syndecan-1","volume":"38","author":"Chen","year":"2018","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1172\/JCI109435","article-title":"Quantitation of the transfer of surface phospholipid of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in the rat","volume":"64","author":"Redgrave","year":"1979","journal-title":"J Clin Invest."},{"key":"B149","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1172\/JCI109564","article-title":"Metabolic fate of chylomicron phospholipids and apoproteins in the rat","volume":"64","author":"Tall","year":"1979","journal-title":"J Clin Invest."},{"key":"B150","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/0005-2760(87)90200-1","article-title":"Serum lipids and lipoproteins in the atherosclerosis prone LA\/N corpulent rat","volume":"919","author":"Dolphin","year":"1987","journal-title":"Biochim Biophys Acta."},{"key":"B151","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fnut.2016.00044","article-title":"Mechanisms of comorbidities associated with the metabolic syndrome: insights from the JCR:LA-cp corpulent rat strain","volume":"3","author":"Diane","year":"2016","journal-title":"Front Nutr."},{"key":"B152","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1042\/BST0350477","article-title":"Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome","volume":"35","author":"Mangat","year":"2007","journal-title":"Biochem Soc Trans."},{"key":"B153","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2015.10.093","article-title":"Apolipoprotein E-deficient rats develop atherosclerotic plaques in partially ligated carotid arteries","volume":"243","author":"Wei","year":"2015","journal-title":"Atherosclerosis."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1038\/s41598-019-38732-2","article-title":"Knockout rat models mimicking human atherosclerosis created by Cpf1-mediated gene targeting","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep."},{"key":"B155","doi-asserted-by":"publisher","first-page":"E559","DOI":"10.1152\/ajpendo.1989.256.4.E559","article-title":"Impaired very low-density lipoprotein-triglyceride catabolism in acute and chronic fructose-fed rats","volume":"256","author":"Hirano","year":"1989","journal-title":"Am J Physiol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1124\/jpet.117.246165","article-title":"Reduction in secretion of very low density lipoprotein-triacylglycerol by a matrix metalloproteinase inhibitor in a rat model of diet-induced hypertriglyceridemia","volume":"366","author":"Kawashima","year":"2018","journal-title":"J Pharmacol Exp Ther."},{"key":"B157","doi-asserted-by":"publisher","first-page":"404085","DOI":"10.1155\/2015\/404085","article-title":"Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches","volume":"2015","author":"Heinonen","year":"2015","journal-title":"J Diabetes Res."},{"key":"B158","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-2275(20)34780-5","article-title":"Animal lipoproteins: chemistry, structure, and comparative aspects","volume":"21","author":"Chapman","year":"1980","journal-title":"J Lipid Res."},{"key":"B159","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0022-2275(20)36966-2","article-title":"Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins","volume":"34","author":"Greeve","year":"1993","journal-title":"J Lipid Res."},{"key":"B160","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0022-2275(20)38413-3","article-title":"Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein","volume":"29","author":"Nagashima","year":"1988","journal-title":"J Lipid Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1161\/01.ATV.18.9.1433","article-title":"Increased angiotensin II type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits","volume":"18","author":"Yang","year":"1998","journal-title":"Arteriosc Thromb Vasc Biol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0005-2760(89)90284-1","article-title":"The rabbit as an animal model of hepatic lipase deficiency","volume":"1002","author":"Clay","year":"1989","journal-title":"Biochim Biophys Acta."},{"key":"B163","unstructured":"Pathologic findings in rabbit models of hereditary hypertriglyceridemia and hereditary postprandial hypertriglyceridemia46580 MitsuguchiY ItoT OhwadaK 19004373Comp Med.582008"},{"key":"B164","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1161\/01.ATV.0000245808.12493.40","article-title":"Hereditary postprandial hypertriglyceridemic rabbit exhibits insulin resistance and central obesity - A novel model of metabolic syndrome","volume":"26","author":"Kawai","year":"2006","journal-title":"Arteriosc Thrombosis Vasc Biol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1742-4658.2011.08401.x","article-title":"Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII","volume":"279","author":"Wei","year":"2012","journal-title":"FEBS J."},{"key":"B166","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s13205-011-0026-4","article-title":"Comparative studies of glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1: evidence for a eutherian mammalian origin for the GPIHBP1 gene from an LY6-like gene","volume":"2","author":"Holmes","year":"2012","journal-title":"3 Biotech."},{"key":"B167","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1752-8062.2011.00298.x","article-title":"Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes","volume":"4","author":"Bremer","year":"2011","journal-title":"Clin Transl Sci."},{"key":"B168","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1194\/jlr.M089508","article-title":"Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference","volume":"60","author":"Butler","year":"2019","journal-title":"J Lipid Res."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1161\/CIRCRESAHA.111.300367","article-title":"Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans","volume":"112","author":"Graham","year":"2013","journal-title":"Circ Res."},{"key":"B170","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/ilar\/ilx031","article-title":"Use and importance of nonhuman primates in metabolic disease research: current state of the field","volume":"58","author":"Havel","year":"2017","journal-title":"ILAR J."},{"key":"B171","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature22034","article-title":"Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity","volume":"544","author":"Saleheen","year":"2017","journal-title":"Nature."},{"key":"B172","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N Engl J Med."},{"key":"B173","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N Engl J Med."},{"key":"B174","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jacc.2016.11.065","article-title":"Very-low-density lipoprotein-associated apolipoproteins predict cardiovascular events and are lowered by inhibition of APOC-III","volume":"69","author":"Pechlaner","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense Inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N Engl J Med."},{"key":"B176","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med."},{"key":"B177","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and triglyceride levels in familial chylomicronemia syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N Engl J Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.atherosclerosissup.2017.05.003","article-title":"The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia","volume":"30","author":"Gouni-Berthold","year":"2017","journal-title":"Atheroscler Suppl."},{"key":"B179","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/2042018817695449","article-title":"Therapeutic plasmapheresis for hypertriglyceridemia-associated acute pancreatitis: case series and review of the literature","volume":"8","author":"Joglekar","year":"2017","journal-title":"Ther Adv Endocrinol Metab."},{"key":"B180","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1124\/jpet.114.220418","article-title":"A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice","volume":"352","author":"Amar","year":"2015","journal-title":"J Pharmacol Exp Ther."},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw7905","article-title":"A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides","volume":"12","author":"Wolska","year":"2020","journal-title":"Sci Transl Med."},{"key":"B182","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","article-title":"ANGPTL3 deficiency and protection against coronary artery disease","volume":"69","author":"Stitziel","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.molmet.2017.06.014","article-title":"ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase","volume":"6","author":"Chi","year":"2017","journal-title":"Mol Metab."},{"key":"B184","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N Engl J Med."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1194\/jlr.M054890","article-title":"ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys","volume":"56","author":"Gusarova","year":"2015","journal-title":"J Lipid Res."},{"key":"B186","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1161\/CIRCULATIONAHA.117.031335","article-title":"Reduced blood lipid levels with in vivo CRISPR-Cas9 base editing of ANGPTL3","volume":"137","author":"Chadwick","year":"2018","journal-title":"Circulation."},{"key":"B187","doi-asserted-by":"publisher","first-page":"28488","DOI":"10.1074\/jbc.M004029200","article-title":"Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene","volume":"275","author":"Kersten","year":"2000","journal-title":"J Biol Chem."},{"key":"B188","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1128\/MCB.20.14.5343-5349.2000","article-title":"Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation","volume":"20","author":"Yoon","year":"2000","journal-title":"Mol Cell Biol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1042\/bj3460603","article-title":"Hepatic expression, synthesis and secretion of a novel fibrinogen\/angiopoietin-related protein that prevents endothelial-cell apoptosis","volume":"346","author":"Kim","year":"2000","journal-title":"Biochem J."},{"key":"B190","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1210\/en.2005-0476","article-title":"Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism","volume":"146","author":"Koster","year":"2005","journal-title":"Endocrinology."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1194\/jlr.C200010-JLR200","article-title":"Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase","volume":"43","author":"Yoshida","year":"2002","journal-title":"J Lipid Res."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/s41588-018-0222-9","article-title":"Genetics of blood lipids among similar to 300,000 multi-ethnic participants of the million veteran program","volume":"50","author":"Klarin","year":"2018","journal-title":"Nat Genet."},{"key":"B193","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12986-018-0308-5","article-title":"ANGPTL4 variants and their haplotypes are associated with serum lipid levels, the risk of coronary artery disease and ischemic stroke and atorvastatin cholesterol-lowering responses","volume":"15","author":"Yang","year":"2018","journal-title":"Nutr Metabol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of coronary artery disease","volume":"374","author":"Dewey","year":"2016","journal-title":"N Engl J Med."},{"key":"B195","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmet.2010.11.002","article-title":"Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages","volume":"12","author":"Lichtenstein","year":"2010","journal-title":"Cell Metab."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00504\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T09:40:07Z","timestamp":1616924407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00504\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":195,"alternative-id":["10.3389\/fendo.2020.00504"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00504","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"article-number":"504"}}